elevated risk of lower blood sugar (hypoglycemia) in patients with variety 2 diabetic issues, especially people who also choose medicines for type 2 diabetes including sulfonylureas or insulin. This may be both of those a significant and common side outcome. Discuss with your Health care supplier regarding how to acknowledge and address small blood